Skip to main content
. Author manuscript; available in PMC: 2012 Feb 13.
Published in final edited form as: J Pharm Pract. 2011 Nov 17;24(6):551–560. doi: 10.1177/0897190011426558

Figure 1.

Figure 1

Prevalence of single-agent misuse of prescribed stimulants as a function of pharmacokinetic properties. Short-/intermediate-acting (3–8 hours); long-acting (8–12 hours) pharmacokinetic properties of each formulation.35